Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism
- 6 August 2008
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 35 (11) , 2097-2104
- https://doi.org/10.1007/s00259-008-0892-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Risk of Thyroid Cancer After Exposure to 131 I in ChildhoodJNCI Journal of the National Cancer Institute, 2005
- Thyroid Neoplasia, Autoimmune Thyroiditis, and Hypothyroidism in Persons Exposed to Iodine 131 From the Hanford Nuclear SiteJAMA, 2004
- Biokinetics of Iodide in Man: Refinement of Current ICRP Dosimetry ModelsCancer Biotherapy & Radiopharmaceuticals, 2003
- Health effects of the Chernobyl accident: fears, rumours and the truthEuropean Journal Of Cancer, 2003
- Radioiodine ( 131 I) treatment of hyperthyroidism: radiation protection and quality assuranceEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Recommended Restrictions After 131I TherapyHealth Physics, 1999
- Radiation dose rates from adult patients receiving 131I therapy for thyrotoxicosisNuclear Medicine Communications, 1993
- Contamination of the home environment by patients treated with Iodine-131: initial results.American Journal of Public Health, 1978
- Radioiodine therapy to out-patients—the radiation hazardThe British Journal of Radiology, 1971
- Radioiodine therapy to out-patients—the contamination hazardThe British Journal of Radiology, 1970